Trio Of Pharma Cos. Fight Post-Trial Bids In $1B Patent Row
Three pharmaceutical companies involved in a $1 billion patent infringement suit over a quality control test for a generic blood thinner contested each other's dueling bids for post-trial relief Wednesday —...To view the full article, register now.
Already a subscriber? Click here to view full article